Why PRP Results Vary So Much From Patient to Patient: What the 2026 Research Actually Found
If you have spent an evening researching PRP for your knee, you have probably read that it is one of the most promising non-surgical options available — and, a few tabs later, that it works no better than a saline shot. Both of those articles were written from real published studies. That is the confusing part, and it is not your fault for being confused.
Two large 2026 analyses have changed what the better question is. It is no longer “does PRP work.” It is “which PRP, prepared how, delivered as part of what plan.” Here is what the research actually says, in plain English, and what it means if you are weighing platelet-rich plasma therapy in Oklahoma City.
First: why the internet disagrees about PRP
In 2025, a team published an overview in Frontiers in Physiology that did something unusual — instead of reviewing the trials, it reviewed the reviews. Looking at 29 systematic reviews and meta-analyses of PRP for knee osteoarthritis, the authors rated 26 of them as critically low methodological quality and the remaining 3 as low quality, using the standard AMSTAR-2 appraisal tool. They also found a very high degree of overlap among the primary studies those reviews drew from.1
Read that again, because it explains a lot. Many of the confident, opposite-sounding headlines you have read are reshuffling the same modest pile of original trials, with varying rigor. When the underlying summaries disagree, patients get whiplash. The authors own conclusion was that the quality of this literature “remains suboptimal.”
That is not a reason to dismiss PRP. It is a reason to be skeptical of anyone — clinic or critic — who tells you the answer is simple.
What is actually in the syringe: the concentration question
PRP is made from your own blood. A sample is drawn, spun in a centrifuge to concentrate the platelets, and the resulting plasma is injected into the joint. The marketing shorthand has long been that more platelets means a better result.
The largest analysis to date complicates that. In April 2026, researchers published a network meta-analysis in Knee Surgery & Related Research covering 56 randomized controlled trials and 5,251 patients, with 53 trials and 5,031 participants entering the network analysis. They compared activated versus non-activated PRP, high-platelet versus low-platelet formulations, and different degrees of white-blood-cell enrichment.2
High-platelet formulations showed no statistical superiority over low-platelet ones. Greater leukocyte enrichment provided no additional benefit. What did show a signal was activation — PRP activation produced significant benefits in specific KOOS domains at 12 months, including activities of daily living, sport and recreation function, and knee-related quality of life. The authors concluded that activation “could play a key role in treatment outcomes” and could compensate for variation in platelet and leukocyte enrichment.
Now the honest counterpoint, because we are not going to pretend this is settled. A 2025 meta-analysis in The American Journal of Sports Medicine pooled 18 randomized trials and 1,995 patients and used a cutoff of 1,000,000 ± 20% platelets/µL to separate formulations. In that analysis, high-platelet PRP delivered pain relief exceeding the minimal clinically important difference at 3, 6, and 12 months, while low-platelet preparations did not reach that threshold for pain.3
So: two Level-I analyses, different answers on the same variable. That is the real state of the field in 2026, and it is precisely why two people can get the same-sounding injection and walk away with different stories.
The second variable almost nobody asks about: what you combine it with
In June 2026, a network meta-analysis in the Journal of Orthopaedic Surgery and Research looked at a question patients rarely think to ask — is PRP better on its own, or paired with something else? Across 18 randomized controlled trials and 1,376 participants, the authors compared PRP alone against PRP combined with hyaluronic acid, with mesenchymal stem cells, and with ozone.4
Only one combination separated itself. PRP plus hyaluronic acid was the single pairing that showed a statistically significant improvement over PRP alone on WOMAC function (mean difference −6.16, 95% CI −9.71 to −2.61, P < 0.001), with a corresponding advantage on VAS pain scores. In the SUCRA rankings it placed first for pain and second for function. The stem cell and ozone combinations showed no significant benefit over PRP alone.
We want to be direct about that last point, because Venturis offers both PRP and ozone-based therapies including prolozone. This analysis looked specifically at ozone added to a PRP knee injection for osteoarthritis — not at ozone as a standalone therapy for other purposes — and in that specific pairing, it did not outperform PRP by itself. We are not going to market a combination the evidence does not currently support. The authors themselves noted sparse data for the non-hyaluronic-acid comparisons, substantial variation in how PRP was prepared across trials, and that these were symptom outcomes rather than structural ones.
What this means if you are considering PRP in Oklahoma City
The practical takeaway is not a number to chase. It is a set of questions worth asking any clinic before you book:
- How is the PRP prepared, and is it activated? Preparation protocols vary widely between clinics, and the 2026 evidence suggests that step deserves more attention than a headline platelet multiple.
- Is the injection guided? Placing an injection accurately inside a joint or at a specific tendon insertion is a skill, and ultrasound guidance exists for a reason.
- What happens in the twelve weeks after? A treatment plan that ends when you walk out the door is not a treatment plan.
- What would make you tell me I am not a candidate? The answer to this one tells you the most.
At Venturis Clinic, Dr. Alvin Philipose has performed regenerative injection procedures in Oklahoma City for more than 25 years, including thousands of prolotherapy treatments. We evaluate whether PRP therapy, prolotherapy, or a combination fits your specific joint and your specific goals, rather than starting from the procedure and working backward.
Who is generally not a good candidate
This section matters more than any of the research above. PRP is not appropriate for everyone, and candidates are typically evaluated for the following during a consultation:
- Active infection, either at the injection site or systemically.
- Platelet or bleeding disorders, or anticoagulant therapy that cannot be safely managed around the procedure.
- Active malignancy. Anyone under oncology care should make these decisions with their oncology team.
- End-stage joint changes with a surgical plan already in motion. Some patients want to explore options before surgery, and that is a reasonable conversation — but PRP is not a substitute for a decision you and your surgeon have already made together.
- Anyone expecting a single-visit fix. Nothing in this literature supports that expectation, and we would rather say so at the consultation than after.
- Anyone unable to participate in the activity and rehabilitation side of the plan, which is where a good share of the durable improvement tends to come from.
Frequently asked questions
Does PRP work for knee arthritis?
Published randomized trials show pain and function improvements for many patients compared with placebo, but the size and durability of that benefit varies considerably between studies, and the overall quality of the review literature has been rated as low. Research suggests PRP may help support symptom improvement in appropriately selected patients; individual results vary and no outcome is guaranteed.
Why do studies about PRP disagree with each other?
Partly because “PRP” is not one product. Preparation protocols, platelet concentration, white-cell content, activation, injection number, and injection technique all differ between trials. And partly because a 2025 overview found that 26 of 29 systematic reviews on PRP for knee osteoarthritis were of critically low methodological quality, with heavy overlap in the underlying trials.
Is a higher platelet concentration better in PRP?
The evidence is genuinely split. A 2025 meta-analysis found that formulations above roughly 1,000,000 platelets/µL reached a clinically meaningful pain threshold where lower-concentration preparations did not. A larger 2026 network meta-analysis of 56 trials found no statistical superiority for high-platelet formulations, and pointed instead to activation as the more important variable.
Does adding hyaluronic acid to PRP help?
In a 2026 network meta-analysis of 18 randomized trials, PRP combined with hyaluronic acid was the only combination that showed a statistically significant improvement over PRP alone on WOMAC function and VAS pain. Whether it is appropriate for you is a question for a consultation.
Does adding ozone to a PRP injection make it work better?
In that same 2026 analysis, ozone combined with PRP did not show a significant benefit over PRP alone for knee osteoarthritis outcomes. The authors also noted the data for that comparison were sparse.
How many PRP injections will I need?
It depends on the joint, the severity, and how you respond. Injection protocols in the published trials vary from a single injection to a series spaced weeks apart. A specific plan is determined during evaluation rather than in advance.
How long does it take to know whether PRP is working?
The trials in these analyses typically measured outcomes at 3, 6, and 12 months, which tells you something about the timescale — this is not designed to work like a steroid shot. Patients may experience gradual change over weeks rather than days. Results vary.
Is PRP FDA-approved for knee osteoarthritis?
No. The centrifuge systems used to prepare PRP are FDA-cleared devices, but PRP itself is not FDA-approved as a treatment for knee osteoarthritis. Any clinic that implies otherwise is overstating it.
Talk it through with someone who does this every day
If you have been told your options are a pill, a steroid injection, or a surgery date, a conversation about whether regenerative options fit your situation is worth having — including the honest version, where the answer may be that they do not.
Dr. Alvin Philipose has practiced regenerative and functional medicine in Oklahoma City for more than 25 years. Book a free 15-minute phone consultation to ask your questions before committing to anything, or request an appointment for a full evaluation. You can also call the clinic directly at (405) 848-7246.
Venturis Clinic
7917 N May Ave, Suite B
Oklahoma City, OK 73120
(405) 848-7246
Monday–Thursday, by appointment
Serving Oklahoma City, Edmond, Norman, Moore, Yukon, Mustang, Piedmont, Bethany, Warr Acres, and Nichols Hills.
This content is for educational purposes only and is not medical advice, diagnosis, or treatment. Individual results vary and no outcome is guaranteed. Venturis Clinic offers regenerative, functional, and alternative medicine services; some therapies discussed are not FDA-approved for the uses described. Talk with a qualified healthcare provider about your specific situation before beginning any treatment.
Sources
- Yi L, Qiu F, Song H, Huang H, Zhang G. Platelet rich plasma injections for knee osteoarthritis: an overview of systematic reviews. Frontiers in Physiology. 2025;16:1598514. DOI: 10.3389/fphys.2025.1598514
- Anitua E, Padilla S, Prado R, Tierno R, Alkhraisat MH. Influence of platelet-rich plasma composition on pain and functional performance in knee osteoarthritis: a systematic review and network meta-analysis. Knee Surgery & Related Research. 2026;38(1):17. DOI: 10.1186/s43019-026-00318-4
- Bensa A, Previtali D, Sangiorgio A, Boffa A, Salerno M, Filardo G. PRP injections for the treatment of knee osteoarthritis: the improvement is clinically significant and influenced by platelet concentration: a meta-analysis of randomized controlled trials. The American Journal of Sports Medicine. 2025;53(3):745–754. DOI: 10.1177/03635465241246524
- Luan D, Zhang X, Zhang Z, Man X, Bo H. Comparative efficacy of platelet-rich plasma monotherapy versus combination therapies for knee osteoarthritis: a systematic review and network meta-analysis. Journal of Orthopaedic Surgery and Research. 2026;21(1):444. DOI: 10.1186/s13018-026-07042-5
Related posts:
